Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications
- PMID: 32294179
- PMCID: PMC7184382
- DOI: 10.1210/endrev/bnaa011
Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications
Abstract
Individuals with diabetes are at increased risk for bacterial, mycotic, parasitic, and viral infections. The severe acute respiratory syndrome (SARS)-CoV-2 (also referred to as COVID-19) coronavirus pandemic highlights the importance of understanding shared disease pathophysiology potentially informing therapeutic choices in individuals with type 2 diabetes (T2D). Two coronavirus receptor proteins, angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase-4 (DPP4) are also established transducers of metabolic signals and pathways regulating inflammation, renal and cardiovascular physiology, and glucose homeostasis. Moreover, glucose-lowering agents such as the DPP4 inhibitors, widely used in subjects with T2D, are known to modify the biological activities of multiple immunomodulatory substrates. Here, we review the basic and clinical science spanning the intersections of diabetes, coronavirus infections, ACE2, and DPP4 biology, highlighting clinical relevance and evolving areas of uncertainty underlying the pathophysiology and treatment of T2D in the context of coronavirus infection.
Keywords: angiotensin converting enzyme 2; diabetes; dipeptidyl peptidase-4; obesity; receptor; virus.
© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
Similar articles
-
COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?J Endocrinol Invest. 2020 Aug;43(8):1053-1060. doi: 10.1007/s40618-020-01318-1. Epub 2020 Jun 3. J Endocrinol Invest. 2020. PMID: 32495299 Free PMC article. Review.
-
COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?J Diabetes. 2020 Sep;12(9):649-658. doi: 10.1111/1753-0407.13052. Epub 2020 May 27. J Diabetes. 2020. PMID: 32394639 Review.
-
Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.Iran J Allergy Asthma Immunol. 2020 May 17;19(S1):10-12. doi: 10.18502/ijaai.v19i(s1.r1).2849. Iran J Allergy Asthma Immunol. 2020. PMID: 32534505
-
Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.Eur Ann Allergy Clin Immunol. 2020 Nov;52(6):282-285. doi: 10.23822/EurAnnACI.1764-1489.169. Epub 2020 Nov 3. Eur Ann Allergy Clin Immunol. 2020. PMID: 32914945 No abstract available.
-
COVID-19 challenging cell biology.Protoplasma. 2020 May;257(3):619-620. doi: 10.1007/s00709-020-01506-z. Epub 2020 Apr 24. Protoplasma. 2020. PMID: 32333127 Free PMC article. No abstract available.
Cited by
-
Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).Immunotherapy. 2021 Jun;13(9):753-765. doi: 10.2217/imt-2020-0349. Epub 2021 Apr 28. Immunotherapy. 2021. PMID: 33906375 Free PMC article.
-
Diabetes and COVID-19: Global and regional perspectives.Diabetes Res Clin Pract. 2020 Aug;166:108303. doi: 10.1016/j.diabres.2020.108303. Epub 2020 Jul 3. Diabetes Res Clin Pract. 2020. PMID: 32623038 Free PMC article.
-
Antidiabetic treatment and COVID-19 Outcomes: A population-based cohort study in primary health care in Catalonia during the first wave of the pandemic.Prim Care Diabetes. 2022 Dec;16(6):753-759. doi: 10.1016/j.pcd.2022.10.001. Epub 2022 Oct 4. Prim Care Diabetes. 2022. PMID: 36216752 Free PMC article.
-
Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.Diabetes Care. 2021 Jul;44(7):1564-1572. doi: 10.2337/dc21-0065. Epub 2021 Jun 16. Diabetes Care. 2021. PMID: 34135013 Free PMC article.
-
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis.Metabolism. 2022 Jun;131:155196. doi: 10.1016/j.metabol.2022.155196. Epub 2022 Mar 31. Metabolism. 2022. PMID: 35367460 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous